SMSC-EVs restore chondrocyte function through S1PR1-mTORC2-mediated mitochondrial fusion and GPS2-HDAC1-driven
Zijian Guo1, Xingjia Mao2, Zehua Wang3
1Department of Orthopedic, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
Osteoarthritis and Cartilage
|July 6, 2026
Summary
Synovial mesenchymal stem cell-derived extracellular vesicles (SMSC-EVs) promote osteoarthritis healing by restoring mitochondrial function and epigenetic regulation. This dual action improves chondrocyte health and reduces cartilage degradation in OA models.
Area of Science:
- Biomedical Science
- Regenerative Medicine
- Osteoarthritis Research
Background:
- Synovial mesenchymal stem cell-derived extracellular vesicles (SMSC-EVs) show promise for osteoarthritis (OA) treatment.
- The precise mechanisms by which SMSC-EVs coordinate mitochondrial and epigenetic repair in OA remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the therapeutic effects of SMSC-EVs in OA.
- To investigate the role of SMSC-EVs in regulating chondrocyte function, mitochondrial integrity, and epigenetic modifications.
Main Methods:
- In vitro assessment of chondrocyte proliferation, apoptosis, and migration.
- Evaluation of mitochondrial function (membrane potential, oxygen consumption, ATP, ROS, network morphology).
- RNA sequencing and proteomics to identify key pathways; validation of molecules (MFN2, S1PR1, GPS2, mTOR) using siRNA and in vivo studies in a rat OA model.
Main Results:
- SMSC-EVs enhanced chondrocyte proliferation and restored mitochondrial function via the S1P-S1PR1-mTORC2-MFN2 pathway.
- EV treatment promoted GPS2 nuclear translocation, leading to interaction with HDAC1 and increased HDAC1 expression, suggesting epigenetic regulation.
- In vivo, SMSC-EVs significantly mitigated cartilage degradation and improved functional outcomes in a rat OA model.
Conclusions:
- SMSC-EVs ameliorate OA through coordinated mitochondrial and epigenetic mechanisms.
- Restoration of mitochondrial integrity involves the S1P-S1PR1-mTORC2-MFN2 pathway.
- Promotion of chondrocyte proliferation is mediated by GPS2-HDAC1-dependent epigenetic regulation, highlighting a synergistic therapeutic strategy for OA.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...